Cambridge, Massachusetts 02138


Purpose:

Accumulating evidence suggests that repeatedly breathing low oxygen levels for brief periods (termed intermittent hypoxia) is a safe and effective treatment strategy to promote meaningful functional recovery in persons with chronic spinal cord injury (SCI). The goal of the study is to understand the mechanisms by which intermittent hypoxia enhances motor function and spinal plasticity (ability of the nervous system to strengthen neural pathways based on new experiences) following SCI.


Study summary:

Accumulating evidence suggests that repeatedly breathing low oxygen levels for brief periods (termed intermittent hypoxia) is a safe and effective treatment strategy to promote meaningful functional recovery in persons with chronic spinal cord injury. Repetitive exposure to mild hypoxia triggers a cascade of events in the spinal cord, including new protein synthesis and increased sensitivity in the circuitry necessary for breathing and walking. Recently, the investigators demonstrated that daily (5 consecutive days) of intermittent hypoxia stimulated walking enhancement in persons with chronic spinal cord injury. Despite these exciting findings, important questions remain. First, does intermittent hypoxia improve walking recovery by increasing strength or muscle coordination or both? Understanding its mechanisms will allow us to best apply intermittent hypoxia in the clinic. Second, initial studies indicate that the beneficial effects of intermittent hypoxia are greatest when intermittent hypoxia is used just prior to task training and that the benefits are greatest for the practiced task. The investigators will explore this possibility by examining the effects of intermittent hypoxia on walking ability and force production when applied alone and when applied in combination with walking training or strength training. The investigators expect that the greatest improvements in walking ability for intermittent hypoxia with walking training and the greatest improvements in strength in response to intermittent hypoxia with strength training. Third, studies suggest that intermittent hypoxia induces spinal plasticity by increasing the expression of a key plasticity-promoting protein, brain-derived neurotrophic factor (BDNF). Mutations in the BDNF gene have been shown to impair BDNF functionality. Thus, the investigators will also explore the impact of BDNF polymorphisms on responsiveness to intermittent hypoxia therapy.


Criteria:

Inclusion Criteria: - Age 18 and 75 years (the latter to reduce likelihood of heart disease) - Medical clearance to participate - Lesion at or below C2 and above T12 with non-progressive etiology - Classified as motor-incomplete with visible volitional leg movement - Injury greater than 1 year Exclusion Criteria: - Concurrent severe medical illness (i.e., infection, cardiovascular disease, ossification, recurrent autonomic dysreflexia, unhealed decubiti, and history of pulmonary complications) - Pregnant women because of the unknown affects of AIH on pregnant women and fetus - History of seizures, brain injury, and/or epilepsy - Undergoing concurrent physical therapy - Diabetes - Cirrhosis - Caffeine and/or NSAID allergies or intolerances


NCT ID:

NCT02323945


Primary Contact:

Principal Investigator
Randy D Trumbower, PT, PhD
Harvard Medical School

Randy D Trumbower, PT, PhD
Phone: 617-952-6951
Email: randy.trumbower@mgh.harvard.edu


Backup Contact:

Email: labtrumbower@gmail.com
Lorna Brown, DPT
Phone: 617-952-6831


Location Contact:

Cambridge, Massachusetts 02138
United States

Randy D Trumbower, PT, PhD
Phone: 617-952-6951
Email: randy.trumbower@mgh.harvard.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: October 18, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.